TCT-554 Laser Atherectomy and Drug-Coated Balloons for the Treatment of Femoropopliteal In-Stent Restenosis: 2-Year Outcomes.

Damianos G. Kokkinidis(Memorial Hospital of South Bend), Ehrin J. Armstrong(University of Denver), Omar Jawaid(Denver VA Medical Center), Stephen W. Waldo(United States Department of Veterans Affairs), Gagan D. Singh(University of California, Davis), Prio Hossain(University of California, Davis), Sean Behan(Denver VA Medical Center)
Journal of the American College of Cardiology
September 23, 2019
10.1016/j.jacc.2019.08.658
Cited by 0

Related Papers

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York
|Metabolism|2020|901
Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity
|JAMA Cardiology|2019|418
Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
|Journal of the American Heart Association|2014|243
Association Between Statin Medications and Mortality, Major Adverse Cardiovascular Event, and Amputation-Free Survival in Patients With Critical Limb Ischemia
|Journal of the American College of Cardiology|2013|188
Clinical Presentation, Management, and Outcomes of Angiographically Documented Early, Late, and Very Late Stent Thrombosis
|JACC: Cardiovascular Interventions|2012|182